Ceapro Inc. announced the granting of stock options and restricted share units to all employees, officers and directors of the Company. In conjunction to these grants and to bolster success, the company also confirmed strategic appointments to the management team including the promotion of Mrs. Leoni DeJoya as Vice President, Bioprocessing Business Unit and the extension of an agreement with Mr. Denis Bilodeau as Strategic Advisor to the Company. Mrs. DeJoya, a certified engineer with over 25 years of experience in international manufacturing and QA/AC joined Ceapro in 2008. As Vice President of Ceapro's newly formed Bioprocessing Business Unit integrating the Company's manufacturing sites, she will be responsible for both technical operations and account management. Mr. Denis Bilodeau, an established clinical, pharmaceutical and medical device expert with 35 years of experience in the public and private sectors will work closely with the CEO for corporate development and Special Projects.